Chinese herbal medicine for advanced non-small-cell lung cancer: a systematic review and meta-analysis

XW Zhang, W Liu, HL Jiang, B Mao - The American journal of …, 2018 - World Scientific
Chinese herbal medicine (CHM) has been widely used in the treatment of advanced non-
small-cell lung cancer (NSCLC), but their efficacy and safety remain controversial. We …

[HTML][HTML] Chinese herbal medicine combined with first-generation EGFR-TKIs in treatment of advanced non-small cell lung cancer with EGFR sensitizing mutation: a …

Y Lu, C Sun, L Jiao, Y Liu, Y Gong, L Xu - Frontiers in Pharmacology, 2021 - frontiersin.org
Background: Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related
deaths worldwide. First-generation epidermal growth factor receptor (EGFR) tyrosine kinase …

Chinese herbal medicine combined with EGFR-TKI in EGFR mutation-positive advanced pulmonary adenocarcinoma (CATLA): a multicenter, randomized, double …

L Jiao, J Xu, J Sun, Z Chen, Y Gong, L Bi… - Frontiers in …, 2019 - frontiersin.org
Background: To determine the clinical activity and safety of Chinese herbal medicine (CHM)
combined with epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKI) in …

[HTML][HTML] Fuzheng Kang-Ai inhibits NSCLC cell proliferation via regulating hsa_circ_0048091/hsa-miR-378g/ARRDC3 pathway

Q Tang, X Wang, Q Zhou, Q Li, X Yang, M Xu, R Wang… - Phytomedicine, 2023 - Elsevier
Background Current treatments for lung cancer have their own deficiencies, such as severe
adverse effect. Therefore, more safe and effective drugs are needed. Purpose Fuzheng …

Reduction in gefitinib resistance mediated by Yi-Fei San-Jie pill in non-small cell lung cancer through regulation of tyrosine metabolism, cell cycle, and the MET/EGFR …

CZ Yang, W Guo, YF Wang, LH Hu, J Wang… - Journal of …, 2023 - Elsevier
Abstract Ethnopharmacological relevance The Chinese herbal prescription Yi-Fei San-Jie
pill (YFSJ) has been used for adjuvant treatment in patients with lung cancer for a long time …

[HTML][HTML] GPX4 plays a crucial role in Fuzheng Kang'ai decoction-induced non-small cell lung cancer cell ferroptosis

YY Zhao, YQ Yang, HH Sheng, Q Tang… - Frontiers in …, 2022 - frontiersin.org
Background: Fuzheng Kang'ai decoction (FZKA) has been widely used to treat Non-Small
Cell Lung Cancer (NSCLC) patients in China for decades, showing definitively curative …

Mechanism of Fuzheng Kang'ai Formula (扶正抗癌方) Regulating Tumor Microenvironment in Non-Small Cell Lung Cancer

Y Tian, S Fu, B Li, L Yuan, Z Bing - Chinese journal of integrative medicine, 2022 - Springer
Objective To study the mechanism of Chinese herbal medicine Fuzheng Kang'ai Formula
(扶正抗癌方, FZKA) on tumor microenvironment (TME). Methods CIBERSORTx was used for …

Multidisciplinary and comprehensive Chinese medicine for advanced non-small cell lung cancer patients: A retrospective study of 855 cases

X Huang, L Zhu, L Zhou, W Xu, Y Yao, Z Zhou… - Chinese journal of …, 2021 - Springer
Objective To investigate the effects of multidisciplinary and comprehensive Chinese
medicine (CM) treatments on progression-free survival (PFS) and median survival time …

[HTML][HTML] FZKA reverses gefitinib resistance by regulating EZH2/Snail/EGFR signaling pathway in lung adenocarcinoma

Q Tang, M Xu, S Long, Y Yu, C Ma, R Wang, J Li… - Journal of …, 2024 - Elsevier
Abstract Ethnopharmacological relevance Fuzheng Kang-Ai (FZKA) decoction is mainly
composed of 12 components with different types of herbs. In the last decade, FZKA has been …

Fuzheng Kang-Ai decoction enhances the effect of Gefitinib-induced cell apoptosis in lung cancer through mitochondrial pathway

S Wang, Z Peng, W Li, S Long, S Xiao, W Wu - Cancer Cell International, 2020 - Springer
Background Our previous clinical study has shown that Chinese herbal medicine (CHM)
Fuzheng Kang-Ai (FZKA) decoction is effective in treating advanced lung cancer patients …